Accelerating diabetes drug discovery (IMAGE)
Caption
Working with medicinal chemist Theodore Kamenecka, Ph.D. (right), Scientific Director Patrick Griffin, Ph.D., of The Wertheim UF Scripps Institute, has designed potential medications for Type 2 diabetes that increase cells' sensitivity to insulin while limiting side effects of older medications. (Photo by Scott Wiseman)
Credit
Scott Wiseman
Usage Restrictions
For use with coverage of research at The Wertheim UF Scripps Institute.
License
Original content